PCT 2013 Vienna

Parexel: Strategic partnerships are reshaping the CRO industry

Parexel and Theorem spoke with us at PCT, Vienna last week on strategic partnerships

Strategic partnerships are “the next phase” of sponsor-CRO relations, according to Parexel, and on top of saving pharma on oversight costs will reshape the industry. 

Private Equity has to exit CRO industry at some point, experts say

Not all good news: CROs must prepare for Private Equity exit, experts say

Merck Serono talks exclusivity in its selection of Quintiles

Quintiles is the "arms, legs and brain" in Merck Serono's monogamous relationship

Patients taking different sort of tablet in clinical trials? Innovation says Pfizer

Pfizer: Active role for patients as smartphones lead way in virtual trials

Economic landscape is bleak, warns expert at PCT yesterday

Regulatory costs will rise, fines will increase, expert warns

Sponsors and CROs talk strategic alliances at PCT in Vienna, Austria

Oversight is key in sponsor-CRO partnerships say Pfizer and Amgen

Hofburg Neue Burg Heldenplatz in Vienna

Ultravox wrong: Vienna 'everything' to CROs this week

Survey: Are strategic alliances good for the CRO industry?

Readers' Survey: Are strategic alliances good for the CRO industry?

More PCT 2013 Vienna